FI65258C - Foerfarande foer framstaellning av en antibiotiskt verkande 7-eta-acylamidocef-3-em-4-karboxylsyra - Google Patents

Foerfarande foer framstaellning av en antibiotiskt verkande 7-eta-acylamidocef-3-em-4-karboxylsyra Download PDF

Info

Publication number
FI65258C
FI65258C FI3713/74A FI371374A FI65258C FI 65258 C FI65258 C FI 65258C FI 3713/74 A FI3713/74 A FI 3713/74A FI 371374 A FI371374 A FI 371374A FI 65258 C FI65258 C FI 65258C
Authority
FI
Finland
Prior art keywords
group
solution
formula
syn
acid
Prior art date
Application number
FI3713/74A
Other languages
English (en)
Finnish (fi)
Other versions
FI65258B (fi
FI371374A (no
Inventor
Janice Bradshaw
Martin Christopher Cook
Gordon Ian Gregory
John Derek Cocker
Derek Ronald Sutherland
Original Assignee
Glaxo Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB59517/73A external-priority patent/GB1496757A/en
Application filed by Glaxo Lab Ltd filed Critical Glaxo Lab Ltd
Publication of FI371374A publication Critical patent/FI371374A/fi
Publication of FI65258B publication Critical patent/FI65258B/fi
Application granted granted Critical
Publication of FI65258C publication Critical patent/FI65258C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FI3713/74A 1973-12-21 1974-12-20 Foerfarande foer framstaellning av en antibiotiskt verkande 7-eta-acylamidocef-3-em-4-karboxylsyra FI65258C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB59517/73A GB1496757A (en) 1973-12-21 1973-12-21 Cephalosporin derivatives
GB5951773 1973-12-21
GB4300574 1974-10-03
GB4300574 1974-10-03

Publications (3)

Publication Number Publication Date
FI371374A FI371374A (no) 1975-06-22
FI65258B FI65258B (fi) 1983-12-30
FI65258C true FI65258C (fi) 1984-04-10

Family

ID=26265028

Family Applications (1)

Application Number Title Priority Date Filing Date
FI3713/74A FI65258C (fi) 1973-12-21 1974-12-20 Foerfarande foer framstaellning av en antibiotiskt verkande 7-eta-acylamidocef-3-em-4-karboxylsyra

Country Status (15)

Country Link
JP (1) JPS5844675B2 (no)
AT (1) AT344888B (no)
CH (1) CH617703A5 (no)
DE (1) DE2460537C2 (no)
DK (1) DK674674A (no)
ES (2) ES433226A1 (no)
FI (1) FI65258C (no)
FR (1) FR2255076B1 (no)
HU (1) HU172234B (no)
IE (1) IE42144B1 (no)
IL (1) IL46302A (no)
LU (1) LU71550A1 (no)
NL (1) NL7416665A (no)
NO (1) NO744621L (no)
SE (1) SE7416195L (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4144392A (en) 1973-12-21 1979-03-13 Glaxo Laboratories Limited Cephalosporins having at position-7 a carboxy substituted α-etherified hydroxyimino-arylacetamido group and at position-3 the residue of a sulphur nucleophile
US4144393A (en) 1973-12-21 1979-03-13 Glaxo Laboratories Limited 3-Acetoxymethyl cephalosporins having at position-7 a carboxy substituted α-etherified hydroxyiminoarylacetamido group
GB1555471A (en) * 1975-06-19 1979-11-14 Glaxo Lab Ltd 7 carbamoylalkoxyimino acetamido 3 em 4 carboxylic acidsand derivatives thereof
CA1093549A (en) * 1976-02-16 1981-01-13 Michael Gregson Cephalosporin antibiotics
US4165430A (en) 1976-03-19 1979-08-21 Glaxo Laboratories Limited Cephalosporins having a 7-carboxy substituted α-etherified oximinoarylacetamido) group
US4304770A (en) 1976-04-12 1981-12-08 Fujisawa Pharmaceutical Co., Ltd. Syn-isomer of 3,7-disubstituted-3-cephem-4-carboxylic acid compounds and processes for the preparation thereof
US4066762A (en) * 1976-07-12 1978-01-03 Smithkline Corporation Derivatives of 7-(2-substituted-2-hydroxyiminoacetamido)-3-(1-substituted tetrazol-5-ylthiomethyl-3-cephem-4-carboxylic acid
US4278670A (en) * 1976-07-12 1981-07-14 Smithkline Corporation 7-Alpha-oxyiminoacylcephalosporins
GB1591439A (en) 1976-10-01 1981-06-24 Glaxo Operations Ltd 7-syn (oxyimino -acylamido) cephalosporins
GB1596278A (en) 1976-11-30 1981-08-26 Glaxo Operations Ltd 7-(-oxyimino-acetamino)cephalosporin derivatives
PH17188A (en) 1977-03-14 1984-06-14 Fujisawa Pharmaceutical Co New cephem and cepham compounds and their pharmaceutical compositions and method of use
SE439312B (sv) * 1977-03-25 1985-06-10 Roussel Uclaf Sett att framstella nya oximderivat av 3-acetoximetyl-7-aminotiazolylacetamido cefalosporansyra
DE2943427A1 (de) * 1978-10-27 1980-05-08 Glaxo Group Ltd Cephalosporinverbindungen
FR2457296A1 (fr) * 1979-05-23 1980-12-19 Rhone Poulenc Ind Nouveaux derives de vinyl-3 cephalosporines et leur preparation
FR2552432B2 (fr) * 1983-09-27 1985-10-25 Roussel Uclaf Nouvelles oximes derivees de l'acide 2-amino thiazol- 4-yl acetique, procede de preparation
US20040166434A1 (en) 2003-02-21 2004-08-26 Dammel Ralph R. Photoresist composition for deep ultraviolet lithography

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3641021A (en) * 1969-04-18 1972-02-08 Lilly Co Eli 3 7-(ring-substituted) cephalosporin compounds
GB1348984A (en) * 1970-06-16 1974-03-27 Merck & Co Inc Antibiotics and processes for their production
GB1399086A (en) * 1971-05-14 1975-06-25 Glaxo Lab Ltd Cephalosporin compounds

Also Published As

Publication number Publication date
NO744621L (no) 1975-07-21
IE42144B1 (en) 1980-06-18
FI65258B (fi) 1983-12-30
DE2460537C2 (de) 1987-01-22
NL7416665A (nl) 1975-06-24
AT344888B (de) 1978-08-10
IE42144L (en) 1975-06-21
FI371374A (no) 1975-06-22
ATA1020174A (de) 1977-12-15
ES451604A1 (es) 1977-12-16
IL46302A (en) 1978-09-29
AU7673574A (en) 1976-06-24
CH617703A5 (en) 1980-06-13
HU172234B (hu) 1978-07-28
IL46302A0 (en) 1975-03-13
LU71550A1 (no) 1976-04-13
JPS50105689A (no) 1975-08-20
FR2255076A1 (no) 1975-07-18
DE2460537A1 (de) 1975-07-03
DK674674A (no) 1975-09-08
ES433226A1 (es) 1977-07-01
FR2255076B1 (no) 1978-11-10
SE7416195L (sv) 1975-09-22
JPS5844675B2 (ja) 1983-10-04

Similar Documents

Publication Publication Date Title
FI65258C (fi) Foerfarande foer framstaellning av en antibiotiskt verkande 7-eta-acylamidocef-3-em-4-karboxylsyra
FI67705C (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara (6,7r)-7-((z)-2-(2-aminotiazol-4-yl)-2-(substituerad oxiimi noacetamido)-(eventuellt substituerat pyridiniummetyl)cef-3 -e-4-karboxylatfoereningar
FI67384B (fi) Foerfarande foer framstaellning av farmaceutiskt anvaendbara 7-(2-(2-imino-4-tiazolin-4-yl)-2-hydroxiiminoacetamido)-3-cefem-4-karboxylsyraderivat
JPH0365350B2 (no)
LU83650A1 (fr) Nouvelles cephalosporines,leur procede de preparation et leur application en therapeutique
EP0136721A2 (en) Carboxyalkenamidocephalosporins
BG60838B2 (bg) Цефалоспоринови производни и метод за тяхното получаване
DK155187B (da) Analogifremgangsmaade til fremstilling af cephalosporinforbindelser i den syn-isomere form eller ugiftige salte deraf
KR830000606B1 (ko) 세팔로스포린 항생제의 제조방법
DK147683B (da) Analogifremgangsmaade til fremstilling af cephalosporinforbindelser eller ugiftige salte, biologisk acceptable estere, 1-oxyder eller solvater deraf
RU2056425C1 (ru) Производные цефалоспорина или их фармацевтически приемлемые кислотно-аддитивные соли и способы их получения
JP2618119B2 (ja) チオアルキルチオセファロスポリン誘導体
US5202315A (en) Cephalosporin compounds
HU193158B (en) Sposob poluchenija 3,7-dizamehhennykh proizvodnykh 3-cefem-4-karbonovykh kislot
NO793688L (no) Fremgangsmaate ved fremstilling av cephalosporinderivater
EP0267733A2 (en) Cephalosporin compounds, process for their preparation and pharmaceutical compositions containing them
EP0265185A2 (en) Cephalosporins, processes for their preparation and pharmaceutical compositions containing them
FI56843C (fi) Foerfarande foer framstaellning av antibakteriella 7-(alfa-amino-p-hydroxifenylacetamido)-3-heterocykliska tiometylcefalosporiner
KR830001891B1 (ko) 세팔로스포린 항생물질의 제조방법
JPS59231090A (ja) フルオロメチルチオオキサセフアロスポリン
CA2053456C (en) Novel cephem compounds, their preparation processes and antibacterial agents
JPS6137274B2 (no)
FI88042C (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara cefalosporansyraderivat
EP0354757A2 (en) Cephalosporins and homologous compounds, process for their preparation and pharmaceutical compositions containing them
KR910008374B1 (ko) 신규 세팔로스포린계 항생제 및 이의 제조방법